StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a report published on Sunday. The brokerage issued a hold rating on the stock.

China Pharma Trading Down 5.4 %

Shares of CPHI opened at $0.27 on Friday. China Pharma has a 1-year low of $0.13 and a 1-year high of $0.41. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. The business’s 50-day moving average price is $0.23 and its 200 day moving average price is $0.22.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.